Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advance Nanotech, Inc. was a diversified nanotechnology company that operated as an incubator and holding company for various nanotech applications, with a significant focus on life sciences. Through its subsidiary, Advance Nanotech Life Sciences, the company collaborated with academic institutions like the University of Cambridge and the University of Missouri to develop nanoparticle-based drug delivery systems and diagnostic sensors. Its most notable legacy is the spin-out of Owlstone, which evolved into the prominent breath-analysis company Owlstone Medical. While the company was a pioneer in the mid-2000s nanotech boom, it eventually ceased active operations and its assets were divested or became independent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advance Nanotech.